Advisor Group Holdings, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 911 shares of HRMY stock, worth $32,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
911
Previous 907
0.44%
Holding current value
$32,140
Previous $36,000
13.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$233 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$206 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$167 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$80.4 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.09B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...